Skip to content

Pilot study Examining the Feasibility and Safety of Excercise Intervention during Palliative Chemotherapy in Patients With Advanced Gastrointestinal Cancer

Feasibility and Safety of Excercise Intervention during Palliative Chemotherapy in Patients With Advanced Gastrointestinal Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005615
Enrollment
30
Registered
2020-11-23
Start date
2020-11-30
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : A) Strength of personalized motion ? Low intensity (total exercise time: 30 minutes) : Subjective motor self-awareness (RPE) 9-10 points, 30% of heart rate reserve i) Warm-up: joint stret

Sponsors

Chung-Ang Univerisity Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - 19 years of age. or older - Patients with progressive digestive cancer (Gastric cancer, colon cancer, pancreatic cancer, biliary cancer) - ECOG performance is 0-1 - those who have a life expectancy of more than three months - Patients who voluntarily decided to

Exclusion criteria

Exclusion criteria: - Patients with impaired cognitive function - Patients who require exercise restriction - Patients with fractures.

Design outcomes

Primary

MeasureTime frame
compliance and attrition rate with exercise intervention

Secondary

MeasureTime frame
Survey of patient exercise satisfaction through questionnaire. Assessment of skeletal muscle index (CT and Inbody), body weight, body mass index (BMI), hand grip strength, six minute walking test (6MWT). Safety, quality of life, progression free survival(PFS) and overall survival(OS)

Countries

Korea, Republic of

Contacts

Public ContactPark Ee

Chung-Ang Univerisity Hospital

putoto@naver.com+82-2-6299-1403

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026